Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIRCAS: IV Iron vs Oral Iron in Major Abdominal Surgery
NCT03295851Phase 4Unknown
- Sponsor
- Singapore General Hospital
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Singapore General Hospital. Primary endpoint: Feasibility of the study at 4 months. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03295851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295851.